Table of Content

1 Study Coverage
1.1 Radiopharmaceuticals in Nuclear Medicine Product Introduction
1.2 Market by Type
1.2.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Diagnostic Radiopharmaceuticals
1.2.3 Therapy Radiopharmaceuticals
1.2.4 Enriched Stable Isotopes
1.3 Market by Application
1.3.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Diagnostic Application
1.3.3 Therapeutic Application
1.3.4 Research
1.3.5 Pharmaceutical
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Estimates and Forecasts 2018-2029
2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region
2.2.1 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2018-2024)
2.2.3 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2024-2029)
2.2.4 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region (2018-2029)
2.3 Global Radiopharmaceuticals in Nuclear Medicine Sales Estimates and Forecasts 2018-2029
2.4 Global Radiopharmaceuticals in Nuclear Medicine Sales by Region
2.4.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Radiopharmaceuticals in Nuclear Medicine Sales by Region (2018-2024)
2.4.3 Global Radiopharmaceuticals in Nuclear Medicine Sales by Region (2024-2029)
2.4.4 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Manufacturers
3.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Manufacturers (2018-2024)
3.1.2 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Radiopharmaceuticals in Nuclear Medicine in 2022
3.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturers
3.2.1 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturers (2018-2024)
3.2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Radiopharmaceuticals in Nuclear Medicine Revenue in 2022
3.3 Global Key Players of Radiopharmaceuticals in Nuclear Medicine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Radiopharmaceuticals in Nuclear Medicine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Radiopharmaceuticals in Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Radiopharmaceuticals in Nuclear Medicine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Radiopharmaceuticals in Nuclear Medicine, Product Offered and Application
3.8 Global Key Manufacturers of Radiopharmaceuticals in Nuclear Medicine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Type
4.1.1 Global Radiopharmaceuticals in Nuclear Medicine Historical Sales by Type (2018-2024)
4.1.2 Global Radiopharmaceuticals in Nuclear Medicine Forecasted Sales by Type (2024-2029)
4.1.3 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2018-2029)
4.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type
4.2.1 Global Radiopharmaceuticals in Nuclear Medicine Historical Revenue by Type (2018-2024)
4.2.2 Global Radiopharmaceuticals in Nuclear Medicine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2018-2029)
4.3 Global Radiopharmaceuticals in Nuclear Medicine Price by Type
4.3.1 Global Radiopharmaceuticals in Nuclear Medicine Price by Type (2018-2024)
4.3.2 Global Radiopharmaceuticals in Nuclear Medicine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Application
5.1.1 Global Radiopharmaceuticals in Nuclear Medicine Historical Sales by Application (2018-2024)
5.1.2 Global Radiopharmaceuticals in Nuclear Medicine Forecasted Sales by Application (2024-2029)
5.1.3 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2018-2029)
5.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Application
5.2.1 Global Radiopharmaceuticals in Nuclear Medicine Historical Revenue by Application (2018-2024)
5.2.2 Global Radiopharmaceuticals in Nuclear Medicine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application (2018-2029)
5.3 Global Radiopharmaceuticals in Nuclear Medicine Price by Application
5.3.1 Global Radiopharmaceuticals in Nuclear Medicine Price by Application (2018-2024)
5.3.2 Global Radiopharmaceuticals in Nuclear Medicine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Radiopharmaceuticals in Nuclear Medicine Market Size by Type
6.1.1 US & Canada Radiopharmaceuticals in Nuclear Medicine Sales by Type (2018-2029)
6.1.2 US & Canada Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2018-2029)
6.2 US & Canada Radiopharmaceuticals in Nuclear Medicine Market Size by Application
6.2.1 US & Canada Radiopharmaceuticals in Nuclear Medicine Sales by Application (2018-2029)
6.2.2 US & Canada Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2018-2029)
6.3 US & Canada Radiopharmaceuticals in Nuclear Medicine Market Size by Country
6.3.1 US & Canada Radiopharmaceuticals in Nuclear Medicine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Radiopharmaceuticals in Nuclear Medicine Sales by Country (2018-2029)
6.3.3 US & Canada Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Radiopharmaceuticals in Nuclear Medicine Market Size by Type
7.1.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Type (2018-2029)
7.1.2 Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2018-2029)
7.2 Europe Radiopharmaceuticals in Nuclear Medicine Market Size by Application
7.2.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Application (2018-2029)
7.2.2 Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2018-2029)
7.3 Europe Radiopharmaceuticals in Nuclear Medicine Market Size by Country
7.3.1 Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country (2018-2029)
7.3.3 Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Radiopharmaceuticals in Nuclear Medicine Market Size
8.1.1 China Radiopharmaceuticals in Nuclear Medicine Sales (2018-2029)
8.1.2 China Radiopharmaceuticals in Nuclear Medicine Revenue (2018-2029)
8.2 China Radiopharmaceuticals in Nuclear Medicine Market Size by Application
8.2.1 China Radiopharmaceuticals in Nuclear Medicine Sales by Application (2018-2029)
8.2.2 China Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Radiopharmaceuticals in Nuclear Medicine Market Size by Type
9.1.1 Asia Radiopharmaceuticals in Nuclear Medicine Sales by Type (2018-2029)
9.1.2 Asia Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2018-2029)
9.2 Asia Radiopharmaceuticals in Nuclear Medicine Market Size by Application
9.2.1 Asia Radiopharmaceuticals in Nuclear Medicine Sales by Application (2018-2029)
9.2.2 Asia Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2018-2029)
9.3 Asia Radiopharmaceuticals in Nuclear Medicine Sales by Region
9.3.1 Asia Radiopharmaceuticals in Nuclear Medicine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2018-2029)
9.3.3 Asia Radiopharmaceuticals in Nuclear Medicine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Radiopharmaceuticals in Nuclear Medicine Market Size by Type
10.1.1 Middle East, Africa and Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Radiopharmaceuticals in Nuclear Medicine Market Size by Application
10.2.1 Middle East, Africa and Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Country
10.3.1 Middle East, Africa and Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Bracco Imaging S.P.A.
11.1.1 Bracco Imaging S.P.A. Company Information
11.1.2 Bracco Imaging S.P.A. Overview
11.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bracco Imaging S.P.A. Recent Developments
11.2 Cambridge Isotope Laboratories, Inc.
11.2.1 Cambridge Isotope Laboratories, Inc. Company Information
11.2.2 Cambridge Isotope Laboratories, Inc. Overview
11.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Cambridge Isotope Laboratories, Inc. Recent Developments
11.3 Cardinal Health, Inc.
11.3.1 Cardinal Health, Inc. Company Information
11.3.2 Cardinal Health, Inc. Overview
11.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Cardinal Health, Inc. Recent Developments
11.4 Covidien, Plc
11.4.1 Covidien, Plc Company Information
11.4.2 Covidien, Plc Overview
11.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Covidien, Plc Recent Developments
11.5 Eczacibasi-Monrol
11.5.1 Eczacibasi-Monrol Company Information
11.5.2 Eczacibasi-Monrol Overview
11.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Eczacibasi-Monrol Recent Developments
11.6 Fujifilm Holdings Corporation
11.6.1 Fujifilm Holdings Corporation Company Information
11.6.2 Fujifilm Holdings Corporation Overview
11.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Fujifilm Holdings Corporation Recent Developments
11.7 GE Healthcare (Subsidiary Of General Electric Company)
11.7.1 GE Healthcare (Subsidiary Of General Electric Company) Company Information
11.7.2 GE Healthcare (Subsidiary Of General Electric Company) Overview
11.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 GE Healthcare (Subsidiary Of General Electric Company) Recent Developments
11.8 IBA Group
11.8.1 IBA Group Company Information
11.8.2 IBA Group Overview
11.8.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 IBA Group Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 IBA Group Recent Developments
11.9 Isotec, Inc. (Sigma-Aldrich)
11.9.1 Isotec, Inc. (Sigma-Aldrich) Company Information
11.9.2 Isotec, Inc. (Sigma-Aldrich) Overview
11.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Isotec, Inc. (Sigma-Aldrich) Recent Developments
11.10 Lantheus Medical Imaging, Inc.
11.10.1 Lantheus Medical Imaging, Inc. Company Information
11.10.2 Lantheus Medical Imaging, Inc. Overview
11.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Lantheus Medical Imaging, Inc. Recent Developments
11.11 Nordion, Inc.
11.11.1 Nordion, Inc. Company Information
11.11.2 Nordion, Inc. Overview
11.11.3 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Nordion, Inc. Recent Developments
11.12 Ntp Radioisotopes (Pty), Ltd.
11.12.1 Ntp Radioisotopes (Pty), Ltd. Company Information
11.12.2 Ntp Radioisotopes (Pty), Ltd. Overview
11.12.3 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Ntp Radioisotopes (Pty), Ltd. Recent Developments
11.13 Siemens Healthcare (Subsidiary Of Siemens AG)
11.13.1 Siemens Healthcare (Subsidiary Of Siemens AG) Company Information
11.13.2 Siemens Healthcare (Subsidiary Of Siemens AG) Overview
11.13.3 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Siemens Healthcare (Subsidiary Of Siemens AG) Recent Developments
11.14 Taiyo Nippon Sanso Corporation
11.14.1 Taiyo Nippon Sanso Corporation Company Information
11.14.2 Taiyo Nippon Sanso Corporation Overview
11.14.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Taiyo Nippon Sanso Corporation Recent Developments
11.15 Urenco Limited
11.15.1 Urenco Limited Company Information
11.15.2 Urenco Limited Overview
11.15.3 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Urenco Limited Recent Developments
11.16 Rotem Industries, Ltd., Inc.
11.16.1 Rotem Industries, Ltd., Inc. Company Information
11.16.2 Rotem Industries, Ltd., Inc. Overview
11.16.3 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Rotem Industries, Ltd., Inc. Recent Developments
11.17 Australian Nuclear Association And Technology Organization (ANSTO)
11.17.1 Australian Nuclear Association And Technology Organization (ANSTO) Company Information
11.17.2 Australian Nuclear Association And Technology Organization (ANSTO) Overview
11.17.3 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Australian Nuclear Association And Technology Organization (ANSTO) Recent Developments
11.18 Board of Radiation And Isotope Technology (BRIT)
11.18.1 Board of Radiation And Isotope Technology (BRIT) Company Information
11.18.2 Board of Radiation And Isotope Technology (BRIT) Overview
11.18.3 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Board of Radiation And Isotope Technology (BRIT) Recent Developments
11.19 Institute of Atomic Energy Polatom Radioisotope Centre
11.19.1 Institute of Atomic Energy Polatom Radioisotope Centre Company Information
11.19.2 Institute of Atomic Energy Polatom Radioisotope Centre Overview
11.19.3 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.19.4 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Institute of Atomic Energy Polatom Radioisotope Centre Recent Developments
11.20 Institute of Isotopes Co., Ltd.
11.20.1 Institute of Isotopes Co., Ltd. Company Information
11.20.2 Institute of Isotopes Co., Ltd. Overview
11.20.3 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.20.4 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Institute of Isotopes Co., Ltd. Recent Developments
11.21 Institute Of Radioelement (IRE)
11.21.1 Institute Of Radioelement (IRE) Company Information
11.21.2 Institute Of Radioelement (IRE) Overview
11.21.3 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue and Gross Margin (2018-2024)
11.21.4 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Institute Of Radioelement (IRE) Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Radiopharmaceuticals in Nuclear Medicine Industry Chain Analysis
12.2 Radiopharmaceuticals in Nuclear Medicine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Radiopharmaceuticals in Nuclear Medicine Production Mode & Process
12.4 Radiopharmaceuticals in Nuclear Medicine Sales and Marketing
12.4.1 Radiopharmaceuticals in Nuclear Medicine Sales Channels
12.4.2 Radiopharmaceuticals in Nuclear Medicine Distributors
12.5 Radiopharmaceuticals in Nuclear Medicine Customers
13 Market Dynamics
13.1 Radiopharmaceuticals in Nuclear Medicine Industry Trends
13.2 Radiopharmaceuticals in Nuclear Medicine Market Drivers
13.3 Radiopharmaceuticals in Nuclear Medicine Market Challenges
13.4 Radiopharmaceuticals in Nuclear Medicine Market Restraints
14 Key Findings in The Global Radiopharmaceuticals in Nuclear Medicine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Diagnostic Radiopharmaceuticals
Table 3. Major Manufacturers of Therapy Radiopharmaceuticals
Table 4. Major Manufacturers of Enriched Stable Isotopes
Table 5. Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Radiopharmaceuticals in Nuclear Medicine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region (2018-2024)
Table 10. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region (2024-2029)
Table 11. Global Radiopharmaceuticals in Nuclear Medicine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Radiopharmaceuticals in Nuclear Medicine Sales by Region (2018-2024) & (K MT)
Table 13. Global Radiopharmaceuticals in Nuclear Medicine Sales by Region (2024-2029) & (K MT)
Table 14. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2018-2024)
Table 15. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2024-2029)
Table 16. Global Radiopharmaceuticals in Nuclear Medicine Sales by Manufacturers (2018-2024) & (K MT)
Table 17. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Manufacturers (2018-2024)
Table 18. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Radiopharmaceuticals in Nuclear Medicine, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Radiopharmaceuticals in Nuclear Medicine Price by Manufacturers 2018-2024 (USD/MT)
Table 22. Global Radiopharmaceuticals in Nuclear Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Radiopharmaceuticals in Nuclear Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceuticals in Nuclear Medicine as of 2022)
Table 24. Global Key Manufacturers of Radiopharmaceuticals in Nuclear Medicine, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Radiopharmaceuticals in Nuclear Medicine, Product Offered and Application
Table 26. Global Key Manufacturers of Radiopharmaceuticals in Nuclear Medicine, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Radiopharmaceuticals in Nuclear Medicine Sales by Type (2018-2024) & (K MT)
Table 29. Global Radiopharmaceuticals in Nuclear Medicine Sales by Type (2024-2029) & (K MT)
Table 30. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Type (2018-2024)
Table 31. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Type (2024-2029)
Table 32. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Type (2018-2024)
Table 35. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Type (2024-2029)
Table 36. Radiopharmaceuticals in Nuclear Medicine Price by Type (2018-2024) & (USD/MT)
Table 37. Global Radiopharmaceuticals in Nuclear Medicine Price Forecast by Type (2024-2029) & (USD/MT)
Table 38. Global Radiopharmaceuticals in Nuclear Medicine Sales by Application (2018-2024) & (K MT)
Table 39. Global Radiopharmaceuticals in Nuclear Medicine Sales by Application (2024-2029) & (K MT)
Table 40. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Application (2018-2024)
Table 41. Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Application (2024-2029)
Table 42. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Application (2018-2024)
Table 45. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Application (2024-2029)
Table 46. Radiopharmaceuticals in Nuclear Medicine Price by Application (2018-2024) & (USD/MT)
Table 47. Global Radiopharmaceuticals in Nuclear Medicine Price Forecast by Application (2024-2029) & (USD/MT)
Table 48. US & Canada Radiopharmaceuticals in Nuclear Medicine Sales by Type (2018-2024) & (K MT)
Table 49. US & Canada Radiopharmaceuticals in Nuclear Medicine Sales by Type (2024-2029) & (K MT)
Table 50. US & Canada Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Radiopharmaceuticals in Nuclear Medicine Sales by Application (2018-2024) & (K MT)
Table 53. US & Canada Radiopharmaceuticals in Nuclear Medicine Sales by Application (2024-2029) & (K MT)
Table 54. US & Canada Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Radiopharmaceuticals in Nuclear Medicine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Radiopharmaceuticals in Nuclear Medicine Sales by Country (2018-2024) & (K MT)
Table 60. US & Canada Radiopharmaceuticals in Nuclear Medicine Sales by Country (2024-2029) & (K MT)
Table 61. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Type (2018-2024) & (K MT)
Table 62. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Type (2024-2029) & (K MT)
Table 63. Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Application (2018-2024) & (K MT)
Table 66. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Application (2024-2029) & (K MT)
Table 67. Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Radiopharmaceuticals in Nuclear Medicine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country (2018-2024) & (K MT)
Table 73. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country (2024-2029) & (K MT)
Table 74. China Radiopharmaceuticals in Nuclear Medicine Sales by Type (2018-2024) & (K MT)
Table 75. China Radiopharmaceuticals in Nuclear Medicine Sales by Type (2024-2029) & (K MT)
Table 76. China Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Radiopharmaceuticals in Nuclear Medicine Sales by Application (2018-2024) & (K MT)
Table 79. China Radiopharmaceuticals in Nuclear Medicine Sales by Application (2024-2029) & (K MT)
Table 80. China Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Radiopharmaceuticals in Nuclear Medicine Sales by Type (2018-2024) & (K MT)
Table 83. Asia Radiopharmaceuticals in Nuclear Medicine Sales by Type (2024-2029) & (K MT)
Table 84. Asia Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Radiopharmaceuticals in Nuclear Medicine Sales by Application (2018-2024) & (K MT)
Table 87. Asia Radiopharmaceuticals in Nuclear Medicine Sales by Application (2024-2029) & (K MT)
Table 88. Asia Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Radiopharmaceuticals in Nuclear Medicine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Radiopharmaceuticals in Nuclear Medicine Sales by Region (2018-2024) & (K MT)
Table 94. Asia Radiopharmaceuticals in Nuclear Medicine Sales by Region (2024-2029) & (K MT)
Table 95. Middle East, Africa and Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2018-2024) & (K MT)
Table 96. Middle East, Africa and Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2024-2029) & (K MT)
Table 97. Middle East, Africa and Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2018-2024) & (K MT)
Table 100. Middle East, Africa and Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2024-2029) & (K MT)
Table 101. Middle East, Africa and Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Radiopharmaceuticals in Nuclear Medicine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2018-2024) & (K MT)
Table 107. Middle East, Africa and Latin America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2024-2029) & (K MT)
Table 108. Bracco Imaging S.P.A. Company Information
Table 109. Bracco Imaging S.P.A. Description and Major Businesses
Table 110. Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 111. Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Bracco Imaging S.P.A. Recent Developments
Table 113. Cambridge Isotope Laboratories, Inc. Company Information
Table 114. Cambridge Isotope Laboratories, Inc. Description and Major Businesses
Table 115. Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 116. Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Cambridge Isotope Laboratories, Inc. Recent Developments
Table 118. Cardinal Health, Inc. Company Information
Table 119. Cardinal Health, Inc. Description and Major Businesses
Table 120. Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 121. Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Cardinal Health, Inc. Recent Developments
Table 123. Covidien, Plc Company Information
Table 124. Covidien, Plc Description and Major Businesses
Table 125. Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 126. Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Covidien, Plc Recent Developments
Table 128. Eczacibasi-Monrol Company Information
Table 129. Eczacibasi-Monrol Description and Major Businesses
Table 130. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 131. Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Eczacibasi-Monrol Recent Developments
Table 133. Fujifilm Holdings Corporation Company Information
Table 134. Fujifilm Holdings Corporation Description and Major Businesses
Table 135. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 136. Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Fujifilm Holdings Corporation Recent Developments
Table 138. GE Healthcare (Subsidiary Of General Electric Company) Company Information
Table 139. GE Healthcare (Subsidiary Of General Electric Company) Description and Major Businesses
Table 140. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 141. GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. GE Healthcare (Subsidiary Of General Electric Company) Recent Developments
Table 143. IBA Group Company Information
Table 144. IBA Group Description and Major Businesses
Table 145. IBA Group Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 146. IBA Group Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. IBA Group Recent Developments
Table 148. Isotec, Inc. (Sigma-Aldrich) Company Information
Table 149. Isotec, Inc. (Sigma-Aldrich) Description and Major Businesses
Table 150. Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 151. Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Isotec, Inc. (Sigma-Aldrich) Recent Developments
Table 153. Lantheus Medical Imaging, Inc. Company Information
Table 154. Lantheus Medical Imaging, Inc. Description and Major Businesses
Table 155. Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 156. Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Lantheus Medical Imaging, Inc. Recent Developments
Table 158. Nordion, Inc. Company Information
Table 159. Nordion, Inc. Description and Major Businesses
Table 160. Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 161. Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Nordion, Inc. Recent Developments
Table 163. Ntp Radioisotopes (Pty), Ltd. Company Information
Table 164. Ntp Radioisotopes (Pty), Ltd. Description and Major Businesses
Table 165. Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 166. Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Ntp Radioisotopes (Pty), Ltd. Recent Developments
Table 168. Siemens Healthcare (Subsidiary Of Siemens AG) Company Information
Table 169. Siemens Healthcare (Subsidiary Of Siemens AG) Description and Major Businesses
Table 170. Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 171. Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Siemens Healthcare (Subsidiary Of Siemens AG) Recent Developments
Table 173. Taiyo Nippon Sanso Corporation Company Information
Table 174. Taiyo Nippon Sanso Corporation Description and Major Businesses
Table 175. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 176. Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Taiyo Nippon Sanso Corporation Recent Developments
Table 178. Urenco Limited Company Information
Table 179. Urenco Limited Description and Major Businesses
Table 180. Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 181. Urenco Limited Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 182. Urenco Limited Recent Developments
Table 183. Rotem Industries, Ltd., Inc. Company Information
Table 184. Rotem Industries, Ltd., Inc. Description and Major Businesses
Table 185. Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 186. Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 187. Rotem Industries, Ltd., Inc. Recent Developments
Table 188. Australian Nuclear Association And Technology Organization (ANSTO) Company Information
Table 189. Australian Nuclear Association And Technology Organization (ANSTO) Description and Major Businesses
Table 190. Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 191. Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 192. Australian Nuclear Association And Technology Organization (ANSTO) Recent Developments
Table 193. Board of Radiation And Isotope Technology (BRIT) Company Information
Table 194. Board of Radiation And Isotope Technology (BRIT) Description and Major Businesses
Table 195. Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 196. Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 197. Board of Radiation And Isotope Technology (BRIT) Recent Developments
Table 198. Institute of Atomic Energy Polatom Radioisotope Centre Company Information
Table 199. Institute of Atomic Energy Polatom Radioisotope Centre Description and Major Businesses
Table 200. Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 201. Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 202. Institute of Atomic Energy Polatom Radioisotope Centre Recent Developments
Table 203. Institute of Isotopes Co., Ltd. Company Information
Table 204. Institute of Isotopes Co., Ltd. Description and Major Businesses
Table 205. Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 206. Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 207. Institute of Isotopes Co., Ltd. Recent Developments
Table 208. Institute Of Radioelement (IRE) Company Information
Table 209. Institute Of Radioelement (IRE) Description and Major Businesses
Table 210. Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 211. Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 212. Institute Of Radioelement (IRE) Recent Developments
Table 213. Key Raw Materials Lists
Table 214. Raw Materials Key Suppliers Lists
Table 215. Radiopharmaceuticals in Nuclear Medicine Distributors List
Table 216. Radiopharmaceuticals in Nuclear Medicine Customers List
Table 217. Radiopharmaceuticals in Nuclear Medicine Market Trends
Table 218. Radiopharmaceuticals in Nuclear Medicine Market Drivers
Table 219. Radiopharmaceuticals in Nuclear Medicine Market Challenges
Table 220. Radiopharmaceuticals in Nuclear Medicine Market Restraints
Table 221. Research Programs/Design for This Report
Table 222. Key Data Information from Secondary Sources
Table 223. Key Data Information from Primary Sources
List of Figures
Figure 1. Radiopharmaceuticals in Nuclear Medicine Product Picture
Figure 2. Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2022 & 2029
Figure 4. Diagnostic Radiopharmaceuticals Product Picture
Figure 5. Therapy Radiopharmaceuticals Product Picture
Figure 6. Enriched Stable Isotopes Product Picture
Figure 7. Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2022 & 2029
Figure 9. Diagnostic Application
Figure 10. Therapeutic Application
Figure 11. Research
Figure 12. Pharmaceutical
Figure 13. Other
Figure 14. Radiopharmaceuticals in Nuclear Medicine Report Years Considered
Figure 15. Global Radiopharmaceuticals in Nuclear Medicine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Radiopharmaceuticals in Nuclear Medicine Revenue 2018-2029 (US$ Million)
Figure 17. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 18. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region (2018-2029)
Figure 19. Global Radiopharmaceuticals in Nuclear Medicine Sales 2018-2029 ((K MT)
Figure 20. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2018-2029)
Figure 21. US & Canada Radiopharmaceuticals in Nuclear Medicine Sales YoY (2018-2029) & (K MT)
Figure 22. US & Canada Radiopharmaceuticals in Nuclear Medicine Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Europe Radiopharmaceuticals in Nuclear Medicine Sales YoY (2018-2029) & (K MT)
Figure 24. Europe Radiopharmaceuticals in Nuclear Medicine Revenue YoY (2018-2029) & (US$ Million)
Figure 25. China Radiopharmaceuticals in Nuclear Medicine Sales YoY (2018-2029) & (K MT)
Figure 26. China Radiopharmaceuticals in Nuclear Medicine Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Asia (excluding China) Radiopharmaceuticals in Nuclear Medicine Sales YoY (2018-2029) & (K MT)
Figure 28. Asia (excluding China) Radiopharmaceuticals in Nuclear Medicine Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Radiopharmaceuticals in Nuclear Medicine Sales YoY (2018-2029) & (K MT)
Figure 30. Middle East, Africa and Latin America Radiopharmaceuticals in Nuclear Medicine Revenue YoY (2018-2029) & (US$ Million)
Figure 31. The Radiopharmaceuticals in Nuclear Medicine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of Radiopharmaceuticals in Nuclear Medicine in the World: Market Share by Radiopharmaceuticals in Nuclear Medicine Revenue in 2022
Figure 33. Global Radiopharmaceuticals in Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2018-2029)
Figure 35. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2018-2029)
Figure 36. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2018-2029)
Figure 37. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2018-2029)
Figure 39. US & Canada Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2018-2029)
Figure 40. US & Canada Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2018-2029)
Figure 41. US & Canada Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application (2018-2029)
Figure 42. US & Canada Radiopharmaceuticals in Nuclear Medicine Revenue Share by Country (2018-2029)
Figure 43. US & Canada Radiopharmaceuticals in Nuclear Medicine Sales Share by Country (2018-2029)
Figure 44. U.S. Radiopharmaceuticals in Nuclear Medicine Revenue (2018-2029) & (US$ Million)
Figure 45. Canada Radiopharmaceuticals in Nuclear Medicine Revenue (2018-2029) & (US$ Million)
Figure 46. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2018-2029)
Figure 47. Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2018-2029)
Figure 48. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2018-2029)
Figure 49. Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application (2018-2029)
Figure 50. Europe Radiopharmaceuticals in Nuclear Medicine Revenue Share by Country (2018-2029)
Figure 51. Europe Radiopharmaceuticals in Nuclear Medicine Sales Share by Country (2018-2029)
Figure 52. Germany Radiopharmaceuticals in Nuclear Medicine Revenue (2018-2029) & (US$ Million)
Figure 53. France Radiopharmaceuticals in Nuclear Medicine Revenue (2018-2029) & (US$ Million)
Figure 54. U.K. Radiopharmaceuticals in Nuclear Medicine Revenue (2018-2029) & (US$ Million)
Figure 55. Italy Radiopharmaceuticals in Nuclear Medicine Revenue (2018-2029) & (US$ Million)
Figure 56. Russia Radiopharmaceuticals in Nuclear Medicine Revenue (2018-2029) & (US$ Million)
Figure 57. China Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2018-2029)
Figure 58. China Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2018-2029)
Figure 59. China Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2018-2029)
Figure 60. China Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application (2018-2029)
Figure 61. Asia Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2018-2029)
Figure 62. Asia Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Type (2018-2029)
Figure 63. Asia Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2018-2029)
Figure 64. Asia Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Application (2018-2029)
Figure 65. Asia Radiopharmaceuticals in Nuclear Medicine Revenue Share by Region (2018-2029)
Figure 66. Asia Radiopharmaceuticals in Nuclear Medicine Sales Share by Region (2018-2029)
Figure 67. Japan Radiopharmaceuticals in Nuclear Medicine Revenue (2018-2029) & (US$ Million)
Figure 68. South Korea Radiopharmaceuticals in Nuclear Medicine Revenue (2018-2029) & (US$ Million)
Figure 69. China Taiwan Radiopharmaceuticals in Nuclear Medicine Revenue (2018-2029) & (US$ Million)
Figure 70. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue (2018-2029)